Zdrowie i gospodarka · 01/04/2011
FDA Guidance on Postmarketing Studies and Clinical Trials for Prescription Drugs and Biological Products
The Food and Drug Administration (FDA) has released a guidance document outlining the implementation of new postmarketing study and clinical trial requirements for prescription drugs and biological products, as mandated by the Food and Drug Administration Amendments Act of 2007.
Source: Federal Register — Health and Human ServicesOpen original release →